Comparative Evaluation of Periglottic Airway Devices With Performed Shape
Launched by UNIVERSITY HOSPITAL OF PATRAS · Nov 28, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
After being informed about the study and potential risks, all patients (\>18 years old scheduled for elective surgery under general anesthesia) giving written informed consent will undergo preoperative screening examination to determine eligibility for study entry. A randomization process has been previously done, according to which the participants have been classified into one of the four groups of the study. Each study group is scheduled to receive one of the four periglottic devices (LM FastrachTM, LM ProsealTM, LM I-GelTM, LM ProtectorTM) while evaluating the ventilation sufficiency an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥18 years old, undergoing elective surgery under general anesthesia
- Exclusion Criteria:
- • Patients \< 18 years old
- • Patients undergoing emergency surgery or trauma patients
- • Obstetric population
- • Patients receiving regional anesthesia
- • Patients to whom the use of periglottic airway device is contraindicated
- • Patients with RODS score ≥ 1 (score to predict difficult laryngeal mask placement 1-4)
- • Patients with anticipated difficult airway, planned for awake intubation
- • Patients' refusal to participate in the trial
Trial Officials
Evanthia Dimitriou, MD
Principal Investigator
University Hospital of Patras
About University Hospital Of Patras
The University Hospital of Patras is a leading academic medical center in Greece, dedicated to advancing healthcare through innovative research, clinical excellence, and education. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous studies across various medical fields. Committed to improving patient outcomes, the University Hospital of Patras collaborates with national and international research institutions, ensuring adherence to the highest ethical and scientific standards in clinical research. Through its robust infrastructure and a team of skilled professionals, the hospital plays a pivotal role in translating research findings into effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patras, Ahaia, Greece
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials